Linvoseltamab
Regeneron
['mmsm']
aa16: hematological toxicity, g3/4 neutropenia, anemia and thrombocytopenia were 31%,24% and 14% #mmsm #myeloma #medtwitter #meded #asco23 #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter